6,582
Views
37
CrossRef citations to date
0
Altmetric
Pediatric Asthma

Pediatric acute asthma exacerbations: Evaluation and management from emergency department to intensive care unit

, MD, , MD, , MD, , MSc, BA & , MD, MPH
Pages 607-617 | Received 21 Apr 2015, Accepted 24 Jun 2015, Published online: 26 Apr 2016

References

  • Malveaux FJ. The state of childhood asthma: introduction. Pediatrics 2009;123:S129–S130.
  • Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics 2009;123:S131–S145.
  • Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief 2012;94:1–8.
  • Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma–United States, 1980–1999. MMWR Surveill Summ 2002;51:1–13.
  • Newacheck PW, Halfon N. Prevalence, impact, and trends in childhood disability due to asthma. Arch Pediatr Adolesc Med 2000;154:287–293.
  • Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005–2009. Natl Health Stat Rep 2011;32:1–14.
  • Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, Weiss ST. FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001;107:61–67.
  • Bateman ED, Buhl R, O'Byrne PM, Humbert M, Reddel HK, Sears MR, Jenkins C, et al. Development and validation of a novel risk score for asthma exacerbations: the risk score for exacerbations. J Allergy Clin Immunol 2014;135:1457–1464.
  • Robroeks CM, van Vliet D, Jobsis Q, Braekers R, Rijkers GT, Wodzig WK, Bast A. Prediction of asthma exacerbations in children: results of a one-year prospective study. Clin Exp Allergy 2012;42:792–798.
  • Restrepo RD, Peters J. Near-fatal asthma: recognition and management. Curr Opin Pulmon Med 2008;14:13–23.
  • McFadden Jr ER. Acute severe asthma. Am J Respir Crit Care Med 2003;168:740–759.
  • Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol 2011;127:145–152.
  • Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001;107:S445–S448.
  • Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 1996;5:27–34.
  • Centers for Disease Control and Prevention (CDC). Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001–2009. MMWR 2011;60:547–552.
  • Lieu TA, Lozano P, Finkelstein JA, Chi FW, Jensvold NG, Capra AM, Quesenberry CP, et al. Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics 2002;109:857–865.
  • Lozano P, Connell FA, Koepsell TD. Use of health services by African-American children with asthma on Medicaid. JAMA 1995;274:469–473.
  • Andrews AL, Teufel II RJ, Basco Jr WT. Low rates of controller medication initiation and outpatient follow-up after ED visits for asthma. J Pediatr 2012;160:325–330.
  • Fisher EB, Strunk RC, Sussman LK, Sykes RK, Walker MS. Community organization to reduce the need for acute care for asthma among African American children in low-income neighborhoods: the Neighborhood Asthma Coalition. Pediatrics 2004;114:116–123.
  • Fisher Jr EB, Sussman LK, Arfken C, Harrison D, Munro J, Sykes RK, Sylvia S, Strunk RC. Targeting high risk groups. Neighborhood organization for pediatric asthma management in the Neighborhood Asthma Coalition. Chest 1994;106:248S–259S.
  • Kit BK, Simon AE, Ogden CL, Akinbami LJ. Trends in preventive asthma medication use among children and adolescents, 1988–2008. Pediatrics 2012;129:62–69.
  • Perry TT, Vargas PA, McCracken A, Jones SM. Underdiagnosed and uncontrolled asthma: findings in rural schoolchildren from the Delta region of Arkansas. Ann Allergy Asthma Immunol 2008;101:375–381.
  • Woolf SH, Aron L. U.S. health in international perspective: shorter lives, poorer health. Panel on understanding cross-national health differences among high-income countries. Washington, DC: National Research Council and Institute of Medicine; 2013.
  • National Heart, Lung, and Blood Institute. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. National Asthma Education and Prevention Program. Bethesda, MD: National Institutes of Health; 2007.
  • Halfon N. Addressing health inequalities in the US: a life course health development approach. Soc Sci Med 1982 2012;74:671–673.
  • Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120:S94–S138.
  • Gorelick MH, Stevens MW, Schultz T, Scribano PV. Difficulty in obtaining peak expiratory flow measurements in children with acute asthma. Pediatr Emerg Care 2004;20:22–26.
  • Eid N, Yandell B, Howell L, Eddy M, Sheikh S. Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics 2000;105:354–358.
  • Lemanske Jr RF, Busse WW. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 2010;125:S95–S102.
  • Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet 1988;1:873–875.
  • Holleman Jr DR, Simel DL. Does the clinical examination predict airflow limitation? JAMA 1995;273:313–319.
  • Wolfenden LL, Diette GB, Krishnan JA, Skinner EA, Steinwachs DM, Wu AW. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 2003;163:231–236.
  • Baxt WG. Prospective application of an asthma severity rule. Acad Emerg Med 2002;9:868–869.
  • van der WD. Promises and pitfalls in the evaluation of pediatric asthma scores. J Pediatr 2000;137:744–746.
  • Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339:1030–1035.
  • Jardin F, Farcot JC, Boisante L, Prost JF, Gueret P, Bourdarias JP. Mechanism of paradoxic pulse in bronchial asthma. Circulation 1982;66:887–894.
  • Canny GJ, Reisman J, Healy R, Schwartz C, Petrou C, Rebuck AS, et al. Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics 1989;83:507–512.
  • Kerem E, Canny G, Tibshirani R, Reisman J, Bentur L, Schuh S, et al. Clinical-physiologic correlations in acute asthma of childhood. Pediatrics 1991;87:481–486.
  • Arnold DH, Gebretsadik T, Sheller JR, Abramo TJ, Hartert TV. Accessory muscle use in pediatric patients with acute asthma exacerbations. Ann Allergy Asthma Immunol 2011;106:344–346.
  • Arnold DH, Gebretsadik T, Abramo TJ, Moons KG, Sheller JR, Hartert TV. The RAD score: a simple acute asthma severity score compares favorably to more complex scores. Ann Allergy Asthma Immunol 2011;107:22–28.
  • Arnold DH, Saville BR, Wang W, Hartert TV. Performance of the Acute Asthma Intensity Research Score (AAIRS) for acute asthma research protocols. Ann Allergy, Asthma Immunol 2012;109:78–79.
  • Busse WW, Lemanske Jr RF, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. The Lancet 2010;376:826–834.
  • Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 2007;119:314–321.
  • Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995;310:1225–1229.
  • Leung TF, To MY, Yeung ACM, Wong YS, Wong GWK, Chan PKS. MUltiplex molecular detection of respiratory pathogens in children with asthma exacerbation. Chest 2010;137:348–354.
  • Sanders DL, Gregg W, Aronsky D. Identifying asthma exacerbations in a pediatric ED: a feasibility study. Into J Med Inform 2006;76:557–564.
  • Gershel JC, Goldman HS, Stein RE, Shelov SP, Ziprkowski M. The usefulness of chest radiographs in first asthma attacks. N Engl J Med 1983;309:336–339.
  • Swischuk LE. Asthma attack: is a chest X-ray necessary? Pediatr Emerg Care 2005;21:468–470.
  • Lewis LM, Ferguson I, House SL, Aubuchon K, Schneider J, Johnson K, Matsuda K. Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma. Chest 2014;145:53–59.
  • Rodrigo GJ, Rodrigo C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J 2005;22:404–408.
  • Meert KL, McCaulley L, Sarnaik AP. Mechanism of lactic acidosis in children with acute severe asthma. Pediatr Crit Care Med 2012;13:28–31.
  • Arnold DH, Moore PE, Abramo TJ, Hartert TV. The dilemma of albuterol dosing for acute asthma exacerbations in pediatric patients. Chest 2011;139:472.
  • Arnold DH, Saville BR, Moore PE, Abramo TJ, Resha DJ, Wang W, Hartert TV. Changes of serum potassium and spirometry during treatment for acute asthma: a double-blind, randomized pilot trial of four albuterol regimens. Proc Ped Acad Soc E- PAS 2011;754618:2011.
  • Arnold DH, Hartert TV. What we need to know about long-acting ss(2)-agonists: deja vu all over again? Am J Respir Crit Care Med 2010;182:1219–1220.
  • Salpeter SR, Wall AJ, Buckley NS. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Am J Med 2010;123:322–328.e2.
  • Shore SA, Moore PE. Regulation of beta-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 2003;137:179–195.
  • Leikin JB, Linowiecki KA, Soglin DF, Paloucek F. Hypokalemia after pediatric albuterol overdose: a case series. Am J Emerg Med 1994;12:64–66.
  • Rakhmanina NY, Kearns GL, Farrar III HC. Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler. Pediatr Emerg Care 1998;14:145–147.
  • Phumeetham S, Bahk TJ, Abd-Allah S, Mathur M. Effect of highdose continuous albuterol nebulization on clinical variables in children with status asthmaticus. Pediatr Crit Care Med 2015;16:e41–e46.
  • Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev (Online) 2013;9:Cd000052.
  • Doan Q, Shefrin A, Johnson D. Cost-effectiveness of metered-dose inhalers for asthma exacerbations in the pediatric ED. Pediatrics 2011;127:e1105–e1111.
  • Kaashmiri M, Shepard J, Goodman B, Lincourt WR, Trivedi R, Ellsworth A, Davis AM. Repeat dosing of albuterol via metereddose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. Pediatr Emerg Care 2010;26:197–202.
  • Aaron SD. The use of ipratropium bromide for the management of acute asthma exacerbation in adults and children: a systematic review. J Asthma 2001;38:521–530.
  • Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2013;8:CD000060.
  • Pollack Jr CV, Pollack ES, Baren JM, Smith SR, Woodruff PG, Clark S, Camargo CA. A prospective multicenter study of patient factors associated with hospital admission from the ED among children with acute asthma. Arch Pediatr Adolesc Med 2002;156:934–940.
  • Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001;155:1329–1334.
  • Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early ED treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001;1:Cd002178.
  • Keeney GE, Gray MP, Morrison AK, Levas MN, Kessler EA, Hill GD, et al. Dexamethasone for acute asthma exacerbations in children: a meta-analysis. Pediatrics 2014;133:493–499.
  • Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics 2003;111:376–383.
  • Derendorf H, Hochhaus G, Mollmann H, Barth J, Krieg M, Tunn S, Mollmann C. Receptor-based pharmacokinetic–harmacodynamic analysis of corticosteroids. J Clin Pharmacol 1993;33:115–123.
  • Cross KP, Paul RI, Goldman RD. Single-dose dexamethasone for mild-to-moderate asthma exacerbations: effective, easy, and acceptable. Can Fam Phys 2011;57:1134–1136.
  • Andrews AL, Wong KA, Heine D, Scott Russell W. A costeffectiveness analysis of dexamethasone versus prednisone in pediatric acute asthma exacerbations. Acad Emerg Med 2012;19:943–948.
  • Szlam S, Arnold DH. Identifying parental preferences for corticosteroid and inhaled beta-agonist delivery mode in children with acute asthma exacerbations. Clin Pediatr 2015;54:15–18.
  • Rowe BH, Camargo Jr CA. The role of magnesium sulfate in the acute and chronic management of asthma. Curr Opin Pulmon Med 2008;14:70–76.
  • Shan Z, Rong Y, Yang W, Wang D, Yao P, Xie J, Liu L. Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: a systematic review and meta-analysis. Respir Med 2013;107:321–330.
  • Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000;154:979–983.
  • Ciarallo L, Sauer AH, Shannon MW. Intravenous magnesium therapy for moderate to severe pediatric asthma: results of a randomized, placebo-controlled trial. J Pediatr 1996;129:809–814.
  • Mohammed S, Goodacre S. Intravenous and nebulised magnesium sulphate for acute asthma: systematic review and meta-analysis. Emerg Med J 2007;24:823–830.
  • Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo Jr CA. Intravenous magnesium sulfate treatment for acute asthma in the ED: a systematic review of the literature. Ann Emerg Med 2000;36:181–190.
  • Kokotajlo S, Degnan L, Meyers R, Siu A, Robinson C. Use of intravenous magnesium sulfate for the treatment of an acute asthma exacerbation in pediatric patients. J Pediatr Pharmacol Ther 2014;19:91–97.
  • Mutlu GM, Factor P. Alveolar epithelial beta2-adrenergic receptors. Am J Respir Cell Mol Biol 2008;38:127–134.
  • Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006;4:Cd002884.
  • Rodrigo GJ, Castro-Rodriguez JA. Heliox-driven beta2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014;112:29–34.
  • Golden C, Xu M, Estrada CM, Arnold DH. Clinical outcomes after bilevel positive airway pressure treatment for acute asthma exacerbations. JAMA Pediatr 2014;169:186–188.
  • Wing R, James C, Maranda LS, Armsby CC. Use of high-flow nasal cannula support in the ED reduces the need for intubation in pediatric acute respiratory insufficiency. Pediatr Emerg Care 2012;28:1117–1123.
  • Jat KR, Chawla D. Ketamine for management of acute exacerbations of asthma in children. Cochrane Database Syst Rev (Online) 2012;11:CD009293.
  • Allen JY, Macias CG. The efficacy of ketamine in pediatric ED patients who present with acute severe asthma. Ann Emerg Med 2005;46:43–50.
  • Denmark TK, Crane HA, Brown L. Ketamine to avoid mechanical ventilation in severe pediatric asthma. J Emerg Med 2006;30:163–166.
  • Green SA, Malice MP, Tanaka W, Tozzi CA, Reiss TF. Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax 2004;59:100–104.
  • Reiss TF, Hill JB, Harman E, Zhang J, Tanaka WK, Bronsky E, Guerreiro D, Hendeles L. Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:1030–1035.
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012;380:2095–2128.
  • Sampson AP, Green CP, Spencer DA, Piper PJ, Price JF. Leukotrienes in the blood and urine of children with acute asthma. Ann NY Acad Sci 1991;629:437–439.
  • Drazen JM, O'Brien J, Sparrow D, Weiss ST, Martins MA, Israel E, Fanta CH. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992;146:104–108.
  • Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF. Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 2000;55:260–265.
  • Camargo Jr CA, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA, Malice MP, et al. A randomized placebocontrolled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125:374–380.
  • Camargo Jr CA, Smithline HA, Malice MP, Green SA, Reiss TF. A randomized controlled trial of intravenous montelukast in acute asthma. Am J Respir Crit Care Med 2003;167:528–533.
  • Morris CR, Becker AB, Pinieiro A, Massaad R, Green SA, Smugar SS, Gurner DM. A randomized, placebo-controlled study of intravenous montelukast in children with acute asthma. Ann Allergy Asthma Immunol 2010;104:161–171.
  • Ramakrishnan R, Migoya E, Knorr B. A population pharmacokinetic model for montelukast disposition in adults and children. Pharm Res 2005;22:532–540.
  • Cheng H, Leff JA, Amin R, Gertz BJ, De Smet M, Noonan N, Rogers JD, et al. Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females. Pharm Res 1996;13:445–448.
  • Migoya E, Kearns GL, Hartford A, Zhao J, van Adelsberg J, Tozzi CA, Knorr B, et al. Pharmacokinetics of montelukast in asthmatic patients 6 to 24 months old. J Clin Pharmacol 2004;44:487–494.
  • Knorr B, Larson P, Nguyen HH, Holland S, Reiss TF, Chervinsky P, Blake K, et al. Montelukast dose selection in 6- to 14-year-olds: comparison of single-dose pharmacokinetics in children and adults. J Clin Pharmacol 1999;39:786–793.
  • Schoors DF, De Smet M, Reiss T, Margolskee D, Cheng H, Larson P, Amin R, Somers G. Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers. Br J Clin Pharmacol 1995;40:277–280.
  • Alansari K, Ahmed W, Davidson BL, Alamri M, Zakaria I, Alrifaai M. Nebulized magnesium for moderate and severe pediatric asthma: a randomized trial. Pediatr Pulmonol 2015 doi: 10.1002/ppul.23158. [Epub ahead of print].
  • Chande VT, Skoner DP. A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients. Ann Emerg Med 1992;21:1111–1115.
  • Dalabih A, Harris ZL, Bondi SA, Arnold DH. Contemporary aminophylline use for status asthmaticus in pediatric ICUs. Chest 2012;141:1122–1123.
  • Dalabih AR, Bondi SA, Harris ZL, Saville BR, Wang W, Arnold DH. Aminophylline infusion for status asthmaticus in the pediatric critical care unit setting is independently associated with increased length of stay and time for symptom improvement. Pulmon Pharm Ther 2014;27:57–61.
  • Perrin K, Wijesinghe M, Healy B, Wadsworth K, Bowditch R, Bibby S, Baker T, et al. Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax 2011;66:937–941.
  • Bohn D, Kissoon N. Acute asthma. Pediatr Crit Care Med 2001;2:151–163.
  • Bratton SL, Newth CJ, Zuppa AF, Moler FW, Meert KL, Berg RA, Berger J, et al. Critical care for pediatric asthma: wide care variability and challenges for study. Pediatr Crit Care Med 2012;13:407–414.
  • Bratton SL, Odetola FO, McCollegan J, Cabana MD, Levy FH, Keenan HT. Regional variation in ICU care for pediatric patients with asthma. J Pediatr 2005;147:355–361.
  • Roberts JS, Bratton SL, Brogan TV. Acute severe asthma: differences in therapies and outcomes among pediatric intensive care units. Crit Care Med 2002;30:581–585.
  • Newth CJ, Meert KL, Clark AE, Moler FW, Zuppa AF, Berg RA, Pollack MM, et al. Fatal and near-fatal asthma in children: the critical care perspective. J Pediatr 2012;161:214–221.e3.
  • Fernandez MM, Villagra A, Blanch L, Fernandez R. Non-invasive mechanical ventilation in status asthmaticus. Intensive Care Med. 2001;27:486–492.
  • Meduri GU, Cook TR, Turner RE, Cohen M, Leeper KV. Noninvasive positive pressure ventilation in status asthmaticus. Chest 1996;110:767–774.
  • Basnet S, Mander G, Andoh J, Klaska H, Verhulst S, Koirala J. Safety, efficacy, and tolerability of early initiation of noninvasive positive pressure ventilation in pediatric patients admitted with status asthmaticus: a pilot study. Pediatric Crit Care Med 2012;13:393–398.
  • Thill PJ, McGuire JK, Baden HP, Green TP, Checchia PA. Noninvasive positive-pressure ventilation in children with lower airway obstruction. Pediatr Crit Care Med 2004;5:337–342.
  • Williams AM, Abramo TJ, Shah MV, Miller RA, Burney-Jones C, Rooks S, Estrada C, Arnold DH. Safety and clinical findings of BiPAP utilization in children 20 kg or less for asthma exacerbations. Intens Care Med 2011;37:1338–1343.
  • Levy BD, Kitch B, Fanta CH. Medical and ventilatory management of status asthmaticusIntensive Care Medicine 1998;24:105–117.
  • Reddy VG. Auto-PEEP: how to detect and how to prevent – a review. Middle East Journal of Anaesthesiology 2005;18:293–312.
  • Martin JG, Shore SA, Engel LA. Mechanical load and inspiratory muscle action during induced asthma. The American Review of Respiratory Disease 1983;128:455–460.
  • Martin JG, Shore S, Engel LA. Effect of continuous positive airway pressure on respiratory mechanics and pattern of breathing in induced asthma. The American Review of Respiratory Disease 1982;126:812–817.
  • Zimmerman JL, Dellinger RP, Shah AN, Taylor RW. Endotracheal intubation and mechanical ventilation in severe asthma. Critical Care Medicine 1993;21:1727–1730.
  • Baren JM, Boudreaux ED, Brenner BE, Cydulka RK, Rowe BH, Clark S, Camargo Jr CA. Randomized controlled trial of ED interventions to improve primary care follow-up for patients with acute asthma. Chest 2006;129:257–265.
  • Zorc JJ, Scarfone RJ, Li Y, Hong T, Harmelin M, Grunstein L, Andre JB. Scheduled follow-up after a pediatric ED visit for asthma: a randomized trial. Pediatrics 2003;111:495–502.
  • Liberman DB, Shelef DQ, He J, McCarter R, Teach SJ. Low rates of follow-up with primary care providers after pediatric ED visits for respiratory tract illnesses. Pediatr Emerg Care 2012;28:956–961.
  • Scarfone RJ, Zorc JJ, Angsuco CJ. Emergency physicians’ prescribing of asthma controller medications. Pediatrics 2006;117:821–827.
  • Lehman HK, Lillis KA, Shaha SH, Augustine M, Ballow M. Initiation of maintenance antiinflammatory medication in asthmatic children in a pediatric ED. Pediatrics 2006;118:2394–2401.
  • Andrews AL, Russell WS, Titus MO, Braden J, Word C, Cochran C, Adams S, Roberts JR. Quality improvement methods improve inhaled corticosteroid prescribing in the ED. J Asthma 2014;51:737–742.
  • Sampayo EM, McLoughlin RJ, Tsevdos D, Alam S, Zorc JJ. Pediatricians support initiation of asthma controller medications in the ED: a national survey. Pediatr Emerg Care 2015;31:545–550.
  • Strikas RA. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years – United States, 2015. MMWR 2015;64:93–94.
  • Dawood FS, Kamimoto L, D'Mello TA, Reingold A, Gershman K, Meek J, Arnold KE, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003–2009. Pediatrics 2011;128:e27–e32.
  • Center for Disease Control and Prevention (CDC). Vaccination coverage among persons with asthma – United States, 2010–2011 influenza season. MMWR 2013;62:973–978.
  • Venkat A, Chan-Tompkins NH, Hegde GG, Chuirazzi DM, Hunter R, Szczesiul JM. Feasibility of integrating a clinical decision support tool into an existing computerized physician order entry system to increase seasonal influenza vaccination in the ED. Vaccine 2010;28:6058–6064.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.